𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Spatiotemporal Localization of VEGF-A Isoforms in the Mouse Postnatal Growth Plate

✍ Scribed by Kristin D. Evans; Anita M. Oberbauer

Publisher
Wiley (John Wiley & Sons)
Year
2007
Tongue
English
Weight
977 KB
Volume
291
Category
Article
ISSN
1932-8486

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Expression of insulin-like growth factor
Expression of insulin-like growth factor system genes during the early postnatal neurogenesis in the mouse hippocampus
✍ Jihui Zhang; Billie M. Moats-Staats; Ping Ye; A. Joseph D'Ercole 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 296 KB 👁 1 views

## Abstract Insulin‐like growth factor‐1 (IGF‐1) is essential to hippocampal neurogenesis and the neuronal response to hypoxia/ischemia injury. IGF (IGF‐1 and ‐2) signaling is mediated primarily by the type 1 IGF receptor (IGF‐1R) and modulated by six high‐affinity binding proteins (IGFBP) and the

In vitro regulation of proliferation and
In vitro regulation of proliferation and differentiation within a postnatal growth plate of the cranial base by parathyroid hormone-related peptide (PTHrP)
✍ Rosamund J. Wealthall 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 351 KB

## Abstract Parathyroid hormone‐related peptide (PTHrP) is known to be an important regulator of chondrocyte differentiation in embryonic growth plates, but little is known of its role in postnatal growth plates. The present study explores the role of PTHrP in regulating postnatal chondrocyte diffe

CXCR4 peptide antagonist inhibits primar
CXCR4 peptide antagonist inhibits primary breast tumor growth, metastasis and enhances the efficacy of anti-VEGF treatment or docetaxel in a transgenic mouse model
✍ Saima Hassan; Marguerite Buchanan; Kaushar Jahan; Adriana Aguilar-Mahecha; Louis 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 527 KB

## Abstract CXCR4 is a chemokine receptor implicated in the homing of cancer cells to target metastatic organs, which overexpress its ligand, stromal cell‐derived factor (SDF)‐1. To determine the efficacy of targeting CXCR4 on primary tumor growth and metastasis, we used a peptide inhibitor of CXCR